Cargando…

Detailed Causality between Sodium-glucose Cotransporter 2 Inhibitor and Tubulointerstitial Nephritis

Detalles Bibliográficos
Autores principales:	Morita, Hiroyasu, Kakeshita, Kota, Imamura, Teruhiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2022
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037002/ https://www.ncbi.nlm.nih.gov/pubmed/35871584 http://dx.doi.org/10.2169/internalmedicine.0124-22

Ejemplares similares

Author's reply: Detailed Causality between Sodium-glucose Cotransporter 2 Inhibitor and Tubulointerstitial Nephritis
por: Konta, Yusuke, et al.
Publicado: (2022)

Tubulointerstitial Nephritis after Using a Sodium-glucose Cotransporter 2 Inhibitor
por: Konta, Yusuke, et al.
Publicado: (2022)

Detailed causality between high‐sensitivity C‐reactive protein and recurrence of atrial fibrillation after catheter ablation
por: Kataoka, Naoya, et al.
Publicado: (2023)

Increased Hematocrit During Sodium-Glucose Cotransporter-2 Inhibitor Therapy
por: Heyman, Samuel N., et al.
Publicado: (2017)

An Effective Insulin Therapy in Combination With Sodium-Glucose Cotransporter 2 Inhibitors
por: Yanai, Hidekatsu, et al.
Publicado: (2019)

Tubulointerstitial nephritis and uveitis syndrome post‐COVID‐19
por: Maggio, Maria Cristina, et al.
Publicado: (2023)

Acute Effects of Preventing Heart Failure by Sodium-Glucose Cotransporter 2 Inhibitors
por: Yanai, Hidekatsu
Publicado: (2021)

Sodium‐glucose cotransporter 2 inhibitors in heart failure with chronic kidney disease
por: Kato, Shingo, et al.
Publicado: (2022)

The Application of Sodium-Glucose Cotransporter 2 Inhibitors to Chronic Kidney Disease Stage 4
por: Koguchi, Ayako, et al.
Publicado: (2017)

The Possible Mechanisms for Improvement of Liver Function due to Sodium-Glucose Cotransporter-2 Inhibitors
por: Yanai, Hidekatsu, et al.
Publicado: (2019)

Detailed association between red blood cell distribution width and heart failure
por: Imamura, Teruhiko
Publicado: (2023)

Detailed association between hepatic dysfunction and tricuspid valve surgery
por: Hida, Yuki, et al.
Publicado: (2023)

Hypothesis on the Etiology of Skin Complications in Japanese Patients Using Sodium-Glucose Cotransporter 2 Inhibitors
por: Suzuki, Yoshihiko
Publicado: (2017)

Perioperative Implication of Sodium-glucose Cotransporter-2 Inhibitor in a Patient Following Major Surgery
por: Vadi, Sonali, et al.
Publicado: (2021)

Detailed association between the etiologies of heart failure and occurrence of sleep‐disordered breathing
por: Nakagawa, Yuri, et al.
Publicado: (2022)

Detailed Pathophysiology of Ischemic Colitis Following Plasma Donation
por: Izumida, Toshihide, et al.
Publicado: (2020)

An Influence of the Estimated Glomerular Filtration Rate on Improvement in Metabolic Parameters by Sodium-Glucose Cotransporter 2 Inhibitors
por: Katsuyama, Hisayuki, et al.
Publicado: (2016)

A Possible Mechanism for Renoprotective Effect of Sodium-Glucose Cotransporter 2 Inhibitor: Elevation of Erythropoietin Production
por: Yanai, Hidekatsu, et al.
Publicado: (2017)

Increased Hematocrit During Sodium-Glucose Cotransporter 2 Inhibitor Therapy Indicates Recovery of Tubulointerstitial Function in Diabetic Kidneys
por: Sano, Motoaki, et al.
Publicado: (2016)

Detailed mechanism and impact of new-onset late right heart failure during LVAD support
por: Imamura, Teruhiko
Publicado: (2020)

Renoprotective effects of sodium glucose cotransporter 2 inhibitors in type 2 diabetes patients with decompensated heart failure
por: Nakagaito, Masaki, et al.
Publicado: (2021)

Acute tubulointerstitial nephritis induced by checkpoint inhibitors versus classical acute tubulointerstitial nephritis: are they the same disease?
por: Draibe, Juliana B, et al.
Publicado: (2020)

What Properties of Sodium-Glucose Cotransporter 2 Inhibitors Determine the Improvement in Hemoglobin A1c and Body Weight?
por: Yanai, Hidekatsu, et al.
Publicado: (2017)

Sodium/Glucose Cotransporter 2 Inhibition and Urolithiasis: The Effect of Urinary pH and Citrate
por: Harmacek, Dusan, et al.
Publicado: (2023)

Sodium-glucose cotransporter 2 inhibitors in cardiology: Slow start and sweet passage
por: Peters, R. J. G.
Publicado: (2021)

Hydrochlorothiazide-induced tubulointerstitial nephritis in a patient with Dent disease
por: Marsenic, Olivera, et al.
Publicado: (2009)

Prescribing Patterns for Sodium-Glucose Cotransporter 2 Inhibitors: A Survey of Nephrologists
por: Singh, Tripti, et al.
Publicado: (2023)

Immune checkpoint inhibitor-induced acute tubulointerstitial nephritis
por: Tan, Hui Zhuan, et al.
Publicado: (2022)

Rapid weight loss in a patient with anti-synthetase syndrome treated with sodium–glucose cotransporter 2 inhibitors and corticosteroids
por: Nawata, Takashi, et al.
Publicado: (2021)

Cardiovascular effects of sodium glucose cotransporter 2 inhibitors
por: Cavaiola, Tricia Santos, et al.
Publicado: (2018)

Hemodynamic Effects of Sodium-Glucose Cotransporter 2 Inhibitors
por: Sano, Motoaki
Publicado: (2017)

Sodium-glucose cotransporter inhibitors: beyond glycaemic control
por: Vergara, Ander, et al.
Publicado: (2019)

Renal outcomes with sodium-glucose cotransporters 2 inhibitors
por: Sun, Xiaoya, et al.
Publicado: (2022)

Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Water and Sodium Metabolism
por: Tang, Jun, et al.
Publicado: (2022)

Immunohistochemical Characteristics of IgG4-Related Tubulointerstitial Nephritis: Detailed Analysis of 20 Japanese Cases
por: Kawano, Mitsuhiro, et al.
Publicado: (2012)

Hypocomplementaemic immune complex tubulointerstitial nephritis
por: Gupta, Alok, et al.
Publicado: (2010)

Tubulointerstitial Nephritis Associated with Enteritis and Sacroiliitis
por: Ushimaru, Shu, et al.
Publicado: (2018)

Tubulointerstitial lesions converted into lupus nephritis
por: Yang, Ning, et al.
Publicado: (2019)

Immunotherapy-Induced Acute Tubulointerstitial Nephritis
por: Parza, Kevin, et al.
Publicado: (2021)

Acute tubulointerstitial nephritis and COVID-19
por: Ng, Jia H, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5t364mauitqmk00nc7olemnk89